← Leaderboards
Ebenezer Tumban
Michigan Technological University
$900,840
Attributed
$900,840
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.2K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$900,840 · 2
By mechanism
R15$900,840 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccine Efficacy”
- Lawrence Corey · Fred Hutchinson Cancer Center$723,976,277
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$536,358,547
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,097,747
- Dennis R. Burton · Scripps Research Institute$259,573,681
- Peter B. Gilbert · Fred Hutchinson Cancer Center$223,862,180
- Barton F Haynes · Duke University$211,151,883
Research focus
Vaccine EfficacyEpitopesInfectionVirus-Like ParticleRefrigerationImmunogenicHuman PapillomavirusImmunogenicityTemperatureVaccinesAntigensBacteriophagesMalignant NeoplasmsCapsidDeveloping CountriesCaliberBaseAnimalsAdvanced DevelopmentFutureGeneral PopulationCold ChainsBacteriaDrug Delivery Systems
Grant awards (3)
Development of a novel and broadly applicable thermostable bacteriophage VLPs platforms for vaccine design, drug delivery, and imaging$389,276
R15 · FY2020 · AI · contact PI
Development of a novel and broadly applicable thermostable bacteriophage VLPs platforms for vaccine design, drug delivery, and imaging$54,367
R15 · FY2020 · AI · contact PI
Development of a Multi-epitope L2 Bacteriophage VLPs Vaccine to Enhance Protection against Oral HPV Infections in HIV patients$457,197
R15 · FY2016 · DE · contact PI